NCT01954043 2017-11-14A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive TumorsGlaxoSmithKlinePhase 1 Completed23 enrolled